Nihon Chouzai (3341) Soars 23% on Buyout Speculation
Second largest dispensing pharmacy chain in Japan considers going private
Japan’s top stock mover today is Nihon Chouzai Co., Ltd. (TSE: 3341)—skyrocketing 23% in Tokyo trading. The dramatic surge comes amid reports that the nationwide dispensing pharmacy chain is exploring a potential take-private deal.
According to a report published by Mergermarket for premium subscribers, Nihon Chouzai has kicked off a bidding process as part of ongoing strategic reviews. While the company hasn't confirmed the report, it did issue a notable statement acknowledging that such a process is indeed underway—but stopped short of saying any decision has been made.
“We have been considering a range of strategic options aimed at enhancing corporate value,” the company said. “As part of those considerations, the reported process is taking place—but no final decision has been made at this time.”
The company added that any material decision would be disclosed “without delay.”
The news has lit a fire under the stock, with investors piling in on the mere possibility of a buyout. Nihon Chouzai, known for its sprawling pharmacy network and growing focus on healthcare tech, has been quietly expanding in a sector where consolidation and strategic shifts are increasingly common.
Today’s spike reflects more than just headline buzz—it highlights how even a whisper of privatization in Japan’s equity landscape can send shares into overdrive.
With a 48% gain year-to-date, Nihon Chouzai is among the top performers on the Tokyo Stock Exchange in 2025. Based on current exchange rates, the company’s market capitalization stands at approximately $375 million. The stock is now trading at its highest level in at least five years.
The stock is trading at an estimated price-to-earnings ratio of 19 based on 2025 forecasts.
Nihon Chouzai has consistently delivered solid revenue growth over the years, often outperforming analyst expectations. Given this track record, it's perhaps not surprising that the company is dissatisfied with its market valuation and is now considering a potential delisting.
Nihon Chouzai Co., Ltd. is a diversified healthcare company in Japan, primarily active in three core areas. Its main business is operating a nationwide chain of dispensing pharmacies. In addition, the company manufactures and distributes generic pharmaceutical products across Japan. Through its staffing division, Nihon Chouzai also provides healthcare personnel services, including the dispatch of pharmacists to pharmacies in various regions.
Together, these segments position the company as a key player in Japan’s healthcare infrastructure—spanning patient-facing retail, drug manufacturing, and professional staffing.
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Investors should conduct their own research or consult with a financial advisor before making any investment decisions.
The stock jumped another 23% Today. Wow, just wow.......